InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
1.20%
)
US TECH 100
17,022.00
(
1.61%
)
Dow Jones
38,503.69
(
0.69%
)
Brent Oil
87.52
(
1.28%
)
Bitcoin
66,113.91
(
-1.11%
)
Post# of 30289
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

UHD

Send PM Follow Ignore
Followers 98
Posts 7584
Boards Moderated 0
Alias Born 03/16/2010

UHD

Re: ~ Blue ~ post# 18987

Tuesday, 06/21/2016 3:24:25 AM

Tuesday, June 21, 2016 3:24:25 AM

Post# of 30289
OPK, FDA Approves New Drug Application for RAYALDEE® to Treat Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Stage 3-4 Chronic Kidney Disease!

Shorts going to scramble to cover with this surprise approval. Not to mention Frost's decision to take the company to the Nasdaq on the 24th. Should be an interesting day/week to say the least.

http://finance.yahoo.com/news/fda-approves-drug-application-rayaldee-060000066.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up